• Something wrong with this record ?

Next-generation sequencing of a combinatorial peptide phage library screened against ubiquitin identifies peptide aptamers that can inhibit the in vitro ubiquitin transfer cascade

M. Lisowska, F. Lickiss, M. Gil-Mir, AS. Huart, Z. Trybala, L. Way, L. Hernychova, A. Krejci, P. Muller, R. Krejcir, I. Zhukow, P. Jurczak, S. Rodziewicz-Motowidło, K. Ball, B. Vojtesek, T. Hupp, U. Kalathiya

. 2022 ; 13 (-) : 875556. [pub] 20221202

Status not-indexed Language English Country Switzerland

Document type Journal Article

Defining dynamic protein-protein interactions in the ubiquitin conjugation reaction is a challenging research area. Generating peptide aptamers that target components such as ubiquitin itself, E1, E2, or E3 could provide tools to dissect novel features of the enzymatic cascade. Next-generation deep sequencing platforms were used to identify peptide sequences isolated from phage-peptide libraries screened against Ubiquitin and its ortholog NEDD8. In over three rounds of selection under differing wash criteria, over 13,000 peptides were acquired targeting ubiquitin, while over 10,000 peptides were selected against NEDD8. The overlap in peptides against these two proteins was less than 5% suggesting a high degree in specificity of Ubiquitin or NEDD8 toward linear peptide motifs. Two of these ubiquitin-binding peptides were identified that inhibit both E3 ubiquitin ligases MDM2 and CHIP. NMR analysis highlighted distinct modes of binding of the two different peptide aptamers. These data highlight the utility of using next-generation sequencing of combinatorial phage-peptide libraries to isolate peptide aptamers toward a protein target that can be used as a chemical tool in a complex multi-enzyme reaction.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031130
003      
CZ-PrNML
005      
20230127131041.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmicb.2022.875556 $2 doi
035    __
$a (PubMed)36532480
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lisowska, Małgorzata $u International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland
245    10
$a Next-generation sequencing of a combinatorial peptide phage library screened against ubiquitin identifies peptide aptamers that can inhibit the in vitro ubiquitin transfer cascade / $c M. Lisowska, F. Lickiss, M. Gil-Mir, AS. Huart, Z. Trybala, L. Way, L. Hernychova, A. Krejci, P. Muller, R. Krejcir, I. Zhukow, P. Jurczak, S. Rodziewicz-Motowidło, K. Ball, B. Vojtesek, T. Hupp, U. Kalathiya
520    9_
$a Defining dynamic protein-protein interactions in the ubiquitin conjugation reaction is a challenging research area. Generating peptide aptamers that target components such as ubiquitin itself, E1, E2, or E3 could provide tools to dissect novel features of the enzymatic cascade. Next-generation deep sequencing platforms were used to identify peptide sequences isolated from phage-peptide libraries screened against Ubiquitin and its ortholog NEDD8. In over three rounds of selection under differing wash criteria, over 13,000 peptides were acquired targeting ubiquitin, while over 10,000 peptides were selected against NEDD8. The overlap in peptides against these two proteins was less than 5% suggesting a high degree in specificity of Ubiquitin or NEDD8 toward linear peptide motifs. Two of these ubiquitin-binding peptides were identified that inhibit both E3 ubiquitin ligases MDM2 and CHIP. NMR analysis highlighted distinct modes of binding of the two different peptide aptamers. These data highlight the utility of using next-generation sequencing of combinatorial phage-peptide libraries to isolate peptide aptamers toward a protein target that can be used as a chemical tool in a complex multi-enzyme reaction.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lickiss, Fiona $u International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland
700    1_
$a Gil-Mir, Maria $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
700    1_
$a Huart, Anne-Sophie $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
700    1_
$a Trybala, Zuzanna $u International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland
700    1_
$a Way, Luke $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
700    1_
$a Hernychova, Lenka $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Krejci, Adam $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Muller, Petr $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Krejcir, Radovan $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Zhukow, Igor $u Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
700    1_
$a Jurczak, Przemyslaw $u Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland
700    1_
$a Rodziewicz-Motowidło, Sylwia $u Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland
700    1_
$a Ball, Kathryn $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
700    1_
$a Vojtesek, Borivoj $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Hupp, Ted $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
700    1_
$a Kalathiya, Umesh $u International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland
773    0_
$w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 13, č. - (2022), s. 875556
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36532480 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131033 $b ABA008
999    __
$a ok $b bmc $g 1889377 $s 1182463
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 13 $c - $d 875556 $e 20221202 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
LZP    __
$a Pubmed-20230119

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...